Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

Castro-Rivera E, Ran S, Thorpe P, Minna JD.

Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11432-7. Epub 2004 Jul 23.


Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.

Castro-Rivera E, Ran S, Brekken RA, Minna JD.

Cancer Res. 2008 Oct 15;68(20):8295-303. doi: 10.1158/0008-5472.CAN-07-6601.


Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.

Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF, Minna JD.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13954-9.


Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor.

Bagnard D, Vaillant C, Khuth ST, Dufay N, Lohrum M, Puschel AW, Belin MF, Bolz J, Thomasset N.

J Neurosci. 2001 May 15;21(10):3332-41.


Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.

Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufeld G.

Cancer Res. 2008 Sep 1;68(17):6922-31. doi: 10.1158/0008-5472.CAN-07-5408.


Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.

Fitzpatrick TE, Lash GE, Yanaihara A, Charnock-Jones DS, Macdonald-Goodfellow SK, Graham CH.

Exp Cell Res. 2003 Feb 15;283(2):247-55.


Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.

Joseph D, Ho SM, Syed V.

Mol Cancer Ther. 2010 Feb;9(2):499-509. doi: 10.1158/1535-7163.MCT-09-0664. Epub 2010 Feb 2.


Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.

Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G.

J Biol Chem. 2007 Sep 7;282(36):26294-305. Epub 2007 Jun 14.


The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment.

Rolny C, Capparuccia L, Casazza A, Mazzone M, Vallario A, Cignetti A, Medico E, Carmeliet P, Comoglio PM, Tamagnone L.

J Exp Med. 2008 May 12;205(5):1155-71. doi: 10.1084/jem.20072509. Epub 2008 May 5.


Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.

Nguyen H, Ivanova VS, Kavandi L, Rodriguez GC, Maxwell GL, Syed V.

Mol Cancer Res. 2011 Nov;9(11):1479-92. doi: 10.1158/1541-7786.MCR-11-0213. Epub 2011 Sep 20.


A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia.

Brusselmans K, Bono F, Collen D, Herbert JM, Carmeliet P, Dewerchin M.

J Biol Chem. 2005 Feb 4;280(5):3493-9. Epub 2004 Nov 29.


Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.

Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, Kaiser LR, Croce CM.

Cancer Res. 2003 Jun 15;63(12):3352-5.


A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.

Barr MP, Byrne AM, Duffy AM, Condron CM, Devocelle M, Harriott P, Bouchier-Hayes DJ, Harmey JH.

Br J Cancer. 2005 Jan 31;92(2):328-33.


Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B.

Koyama N, Zhang J, Huqun, Miyazawa H, Tanaka T, Su X, Hagiwara K.

Oncogene. 2008 Nov 20;27(51):6581-9. Epub 2008 Aug 11.


Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.

Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, Levi BZ, Neufeld G.

J Biol Chem. 1995 Jun 23;270(25):15059-65.


Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.

Vintonenko N, Pelaez-Garavito I, Buteau-Lozano H, Toullec A, Lidereau R, Perret GY, Bieche I, Perrot-Applanat M.

Cell Adh Migr. 2011 Jul-Aug;5(4):332-43. doi: 10.4161/cam.5.4.17287.


Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.

Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.

Life Sci. 2006 Nov 17;79(25):2370-81. Epub 2006 Aug 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk